# FDA Inspection 1284380 - RegenTX Partners LLC - October 17, 2025

Source: https://www.keypedia.com/records/fda_inspections/regentx-partners-llc/92aab561-b23b-43c8-9d30-b59ef3efbc21
Source feed: FDA_Inspections

> FDA Inspection 1284380 for RegenTX Partners LLC on October 17, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1284380
- Company Name: RegenTX Partners LLC
- Inspection Date: 2025-10-17
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics

## Related Documents

- [FDA Inspection 1284380 - 2025-10-17](https://www.keypedia.com/records/fda_inspections/regentx-partners-llc/be27757f-4c9e-4f84-b296-476ead3b9c6f)
- [FDA Inspection 1228236 - 2024-01-23](https://www.keypedia.com/records/fda_inspections/regentx-partners-llc/c95317a3-642a-40e6-bbe2-04b8f0d981c6)
- [FDA Inspection 1113167 - 2019-11-15](https://www.keypedia.com/records/fda_inspections/regentx-partners-llc/afc93693-339d-45e9-85c0-5b929eb4f482)

Company: https://www.keypedia.com/companies/regentx-partners-llc/f392bf7b-b4a0-4737-8f61-01cc223ce55f